Joseph Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joseph Park has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Jae Mo Park
University of Texas Southwestern Medical Center
2 shared publications - Zohreh Erfani
Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States, 75390
2 shared publications - Abdallah Elnwasany
Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center , Dallas, TX 75390
1 shared publication - Baljeet Seniwal
Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States, 75390
1 shared publication - Crystal Harrison
Advanced Imaging Research Center
1 shared publication - Erik J. Plautz
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
1 shared publication
Latest Publications
- Open Access
Traumatic brain injury alters hepatic gluconeogenic metabolism assessed using hyperpolarized pyruvate
Background: Acute phase response is an early immunometabolic response to brain injuries, primarily coordinated by the liver via the activation of acute phase proteins. These immune responses can be both beneficial, promoting tissue repair, and detrimental, exacerbating neurological deficits, if not properly controlled. Despite the central role of the liver in immunometabolism, how hepatic metabolism dynamically adapts to traumatic brain injury remains under explored, primarily due to limited liver-specific modalities that can assess metabolic pathways in vivo . 13 C MRI utilizing hyperpolarized 13 C-pyruvate can assess key regulatory enzyme activities in hepatic metabolism. Methods: Rats with controlled cortical impact were studied in vivo using hyperpolarized [1- 13 C]pyruvate and [2- 13 C]pyruvate under fed and fasted conditions 3-4 days after injury. Hyperpolarized 13 C products, including [ 13 C]bicarbonate from [1- 13 C]pyruvate and [5- 13 C]glutamate, [1- 13 C]acetyl-L-carnitine, and [2- 13 C]phosphoenolpyruvate from [2- 13 C]pyruvate, were evaluated to assess mitochondrial and gluconeogenic metabolism. In parallel, liver tissues were collected following [U- 13 C 3 ]pyruvate injection for NMR isotopomer analysis of phosphoenolpyruvate, glucose, and glutamate. Results: While no metabolic differences were detected under fed condition, [ 13 C]bicarbonate and [2- 13 C]phosphoenolpyruvate increased after brain injury under fasted condition, indicating an upregulation of the hepatic gluconeogenic pathway after injury. 13 C NMR of liver tissue extracts from injured rats showed an elevated [2,3- 13 C 2 ]glutamate-to-[4,5- 13 C 2 ]glutamate ratio and increased 13 C-labeling in phosphoenolpyruvate than controls, confirming enhanced hepatic gluconeogenic pathway. Conclusion: This study demonstrates that hepatic acute phase response to brain injuries can be monitored in vivo by hyperpolarized pyruvate, which may be further utilized for longitudinal immunometabolic evaluation of the liver during pathogenesis and therapeutic interventions.
Open AccessTraumatic brain injury alters hepatic gluconeogenic metabolism assessed using hyperpolarized pyruvate
Background: Acute phase response is an early immunometabolic response to brain injuries, primarily coordinated by the liver via the activation of acute phase proteins. These immune responses can be both beneficial, promoting tissue repair, and detrimental, exacerbating neurological deficits, if not properly controlled. Despite the central role of the liver in immunometabolism, how hepatic metabolism dynamically adapts to traumatic brain injury remains under explored, primarily due to limited liver-specific modalities that can assess metabolic pathways in vivo . 13 C MRI utilizing hyperpolarized 13 C-pyruvate can assess key regulatory enzyme activities in hepatic metabolism. Methods: Rats with controlled cortical impact were studied in vivo using hyperpolarized [1- 13 C]pyruvate and [2- 13 C]pyruvate under fed and fasted conditions 3-4 days after injury. Hyperpolarized 13 C products, including [ 13 C]bicarbonate from [1- 13 C]pyruvate and [5- 13 C]glutamate, [1- 13 C]acetyl-L-carnitine, and [2- 13 C]phosphoenolpyruvate from [2- 13 C]pyruvate, were evaluated to assess mitochondrial and gluconeogenic metabolism. In parallel, liver tissues were collected following [U- 13 C 3 ]pyruvate injection for NMR isotopomer analysis of phosphoenolpyruvate, glucose, and glutamate. Results: While no metabolic differences were detected under fed condition, [ 13 C]bicarbonate and [2- 13 C]phosphoenolpyruvate increased after brain injury under fasted condition, indicating an upregulation of the hepatic gluconeogenic pathway after injury. 13 C NMR of liver tissue extracts from injured rats showed an elevated [2,3- 13 C 2 ]glutamate-to-[4,5- 13 C 2 ]glutamate ratio and increased 13 C-labeling in phosphoenolpyruvate than controls, confirming enhanced hepatic gluconeogenic pathway. Conclusion: This study demonstrates that hepatic acute phase response to brain injuries can be monitored in vivo by hyperpolarized pyruvate, which may be further utilized for longitudinal immunometabolic evaluation of the liver during pathogenesis and therapeutic interventions.
- Open Access
- 26 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (6) , 723-733
In vivo assessment of the recovery of myocardial pyruvate dehydrogenase activity following a ketogenic diet
Aims: A ketogenic diet (KD) can suppress cardiac carbohydrate utilization, which may adversely impact heart function. However, the reversibility of KD-induced metabolic changes is poorly understood. This study aims to characterize myocardial pyruvate dehydrogenase (PDH) flux during the transition from a prolonged KD to a normal chow diet (ND). Methods and results: Cardiac metabolism was longitudinally assessed in rats using hyperpolarized [1-13C]pyruvate at baseline, during a KD (2 and 5 weeks), and a subsequent ND (1, 2, 5, and 8 days) after the 5-week KD. Hyperpolarized 13C products were compared between the KD group and age-matched ND controls. In parallel, nuclear magnetic resonance isotopomer analysis of cardiac tissue with an injection of [3-13C]pyruvate and [1,2-13C2]acetate was performed along with ex vivo enzymatic analysis of PDH activity. Myocardial [13C]bicarbonate production relative to total 13C products decreased from 8.56 ± 2.29% at baseline to 0.46 ± 0.27% after 5 weeks of KD. Reverting to ND gradually restored PDH flux (8.40 ± 1.47% by Day 8) to control levels (8.69 ± 2.10%). Ex vivo NMR analysis of glutamate C4 showed reduced pyruvate contribution to acetyl-CoA during KD (4.1 ± 2.5%), which recovered upon reverting to ND (22.7 ± 1.82% vs. control: 27.6 ± 9.5%). Although PDK4 expression normalized, PDH activity remained partially impaired in the reverted group (36.80 ± 6.07 mmol NADH/min/mg) compared to controls (90.97 ± 5.40; P = 0.00007). Conclusion: KD-induced suppression of myocardial PDH flux is reversible, but its recovery requires significant time, with prolonged metabolic inflexibility persisting after transitioning to an ND. These findings highlight the value of in vivo assessment of cardiac PDH activity, complemented by conventional enzymatic analyses, to identify persistent metabolic inflexibility following ketogenic interventions.
- 26 February 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (6) , 723-733
Open AccessIn vivo assessment of the recovery of myocardial pyruvate dehydrogenase activity following a ketogenic diet
Aims: A ketogenic diet (KD) can suppress cardiac carbohydrate utilization, which may adversely impact heart function. However, the reversibility of KD-induced metabolic changes is poorly understood. This study aims to characterize myocardial pyruvate dehydrogenase (PDH) flux during the transition from a prolonged KD to a normal chow diet (ND). Methods and results: Cardiac metabolism was longitudinally assessed in rats using hyperpolarized [1-13C]pyruvate at baseline, during a KD (2 and 5 weeks), and a subsequent ND (1, 2, 5, and 8 days) after the 5-week KD. Hyperpolarized 13C products were compared between the KD group and age-matched ND controls. In parallel, nuclear magnetic resonance isotopomer analysis of cardiac tissue with an injection of [3-13C]pyruvate and [1,2-13C2]acetate was performed along with ex vivo enzymatic analysis of PDH activity. Myocardial [13C]bicarbonate production relative to total 13C products decreased from 8.56 ± 2.29% at baseline to 0.46 ± 0.27% after 5 weeks of KD. Reverting to ND gradually restored PDH flux (8.40 ± 1.47% by Day 8) to control levels (8.69 ± 2.10%). Ex vivo NMR analysis of glutamate C4 showed reduced pyruvate contribution to acetyl-CoA during KD (4.1 ± 2.5%), which recovered upon reverting to ND (22.7 ± 1.82% vs. control: 27.6 ± 9.5%). Although PDK4 expression normalized, PDH activity remained partially impaired in the reverted group (36.80 ± 6.07 mmol NADH/min/mg) compared to controls (90.97 ± 5.40; P = 0.00007). Conclusion: KD-induced suppression of myocardial PDH flux is reversible, but its recovery requires significant time, with prolonged metabolic inflexibility persisting after transitioning to an ND. These findings highlight the value of in vivo assessment of cardiac PDH activity, complemented by conventional enzymatic analyses, to identify persistent metabolic inflexibility following ketogenic interventions.